Arecor Therapeutics plc (AREC.L) LSE

77.48

+3.48(+4.70%)

Updated at December 05 09:53AM

Currency In GBp

Valuation

Market Cap24.58M
Enterprise Value21.57M
P/E Ratio-3.61
PEG Ratio-0.14
Price/Sales Ratio5.78
Price/Book Ratio10.24
Enterprise/Revenue5.45
Enterprise/EBITDA-3.44

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-1.6
Operating Margin-1.16

Management Effectiveness

Return On Assets-1.54
Return On Equity-1.98

Income Statement

Revenue5.05M
Revenue/Share0.13
Gross Profit1.54M
EBITDA-10.15M
Net Income-10.24M
Diluted EPS-0.31

Balance Sheet

Total Cash1.89M
Total Cash/Share0.05
Total Debt173,000
Total Debt/Equity0.06
Current Ratio2.05
Book Value Per Share0.08

Price History

52-Week Change1.28
52-Week High100
52-Week Low35.4
Moving Average 50 Days75.66
Moving Average 200 Days56.5

Statistics

Average Volume35,142
Shares Outstanding37.76M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A